ICON has entered a strategic alliance with Boston Clinical Research Institute (BCRI), an Academic Research Organization. The alliance will combine BCRI’s leadership in clinical strategy, study planning and academic relationships with ICON’s experience in the execution of global clinical trials.

BCRI provides scientific consultancy in study design using expert clinicians and key opinion leaders from premier medical institutions, and also maintains a network of global investigators in all of the medical specialties and subspecialties.

“We are extremely pleased to announce the partnership with ICON,” said Dr. Michael Gibson, founder and senior consultant at BCRI. “We believe that the future of clinical research is collaboration between the ARO and the CRO. ICON clearly recognizes the incremental benefits of collaboration with the thought leaders in the medical community to optimize study planning, execution, and credibility.”

Peter Gray, chief executive officer at ICON, said, “We are delighted that Dr. Gibson and BCRI have aligned with ICON. The relationship provides ICON and its clients with access to a breadth of expertise in the key opinion leader community and to investigators worldwide, including national and international leaders. Anticipated benefits include enhanced planning, design, site selection and enrolment performance.”